
Massive Investment in Alzheimer’s Drug Kisunla
Ely Lilly unveils new $1,000,000,000 facility for drugs including Kisunla for Alzheimer’s. New investment will enhance global medicine production, benefiting millions of patients worldwide

Ely Lilly unveils new $1,000,000,000 facility for drugs including Kisunla for Alzheimer’s. New investment will enhance global medicine production, benefiting millions of patients worldwide

In a new Alzheimer’s study, Rexulti (brexpiprazole) significantly reduced agitation. Learn the kinds of agitation it reduced and by how much.

There are no approved treatments for DLB, though it is the second most common type of dementia. Do drugs like donepezil hold the key?

While the initial headlines might seem discouraging, there’s always more to the story. 🌟

The newest Alzheimer’s drugs, Kisunla and Leqembi, are the first to actually slow down Alzheimer’s. How do they compare to each other?

VIDEO + ARTICLE: Kisunla (generic name: Donanemab) slowed cognitive and functional decline 35%. Once-monthly infusions reduced Alzheimer’s plaque 84%.

China is the third country to launch LEQEMBI for sale, to fight Alzheimer’s, following the United States and Japan.

Three FDA-Approved drugs, terazosin, doxazosin, and alfuzosin, have a happy side effect; they boost energy production in brain cells. New studies suggest this slows or prevents Dementia with Lewy Bodies.

Grandma hates taking her medications. With her dementia, she ends up asking 10 different times why she has to take it! What should I do?

The unanimous 11-0 FDA vote clears an exciting path for this new Alzheimer’s drug.

In this web exclusive, Microsoft co-founder and philanthropist Bill Gates talks with CBS News chief medical correspondent Dr. Jon LaPook about research into Alzheimer’s, a disease which affected his own father.

In November 1994, President Reagan hand-wrote this profound message to America, sharing his Alzheimer’s diagnosis. His words broke stigmas and myths. Watch Nancy Reagan describe that moment. Read his magnificent letter.

Every dementia journey is unique — but large studies now show clear patterns. Age, type of dementia, and general health all play major roles in how long a person lives after diagnosis.

It is one of the most beautiful Compensations of this life thatNo man can sincerely try to help anotherWithout helping himself.

What are the early symptoms of Alzheimer’s? When to get a professional evaluation.

SHORT-TERM MEMORY lapses are obvious signs of Alzheimer’s, but other tell-tale signals begin to show much earlier. Learn how to look for semantic impairments, such as simple questions about size.

Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
No spam, only news and updates.


